A new project has been launched to accelerate the development and availability of H5N1 avian influenza mRNA vaccines for low- and middle-income countries (LMICs).
About
H5N1 is a subtype of the influenza virus that primarily affects birds but can infect humans and other animals.
It poses a significant risk due to its potential to cause a future pandemic.
mRNA Vaccines:
Mechanism: mRNA vaccines use messenger RNA to instruct cells to produce a protein that triggers an immune response without using a live virus.
They can be developed and produced faster than traditional vaccines.